Abstract
In previous research we examined the science base of US biotechnology utilizing several unique patent and scientific paper databases (McMillan et al., 2000). Our findings highlighted the importance of public science in this industry. In this current research effort, we extend that analysis to include the subsequent citations those biotechnology patents received. Our conclusions are that the reliance on public science is stable when adjusted for forward citations, but the impact of different funding sources does change when citation weights are added. The science policy implications of these findings and future research opportunities are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albert, M. B., Avery, D., Narin, F., McAllister, P. (1991), Direct validation of citation counts as indicators of industrially important patents, Research Policy, 20: 251–259.
Arrow, K. (1962), Economics of welfare and the allocation of resources for invention. In: National Bureau of Economic Research, The Rate and Direction of Inventive Activity. Princeton University Press, Princeton, NJ.
Audretsch, D. B., Stephan, P. (1996), Company-scientist locational linkages: The case of biotechnology, American Economic Review, 86: 641–652.
Cohen, W. M., Levinthal, D. A. (1990), Absorptive capacity: A new perspective on learning and innovation, Administrative Science Quarterly, 35: 128–152.
Dasgupta, P., David, P. (1994), Toward a new economics of science, Research Policy, 23: 487–521.
Fleming, L., Sorenson, O. (2004), Science as a map in technological search, Strategic Management Journal, 25: 909–928.
Hall, B., Jaffe, A., Trajtenberg, M. (2005), Market value and patent citations, RAND Journal of Economics, 36: 16–38.
Harboff, D., Narin, F., Scherer, F., Vopel, K. (1999), Citation frequency and the value of patented inventions, The Review of Economics and Statistics, 81: 511–515.
Liebeskind, J., Oliver, A., Zucker, L., Brewer, M. (1996), Social networks, learning, and flexibility: sourcing scientific knowledge in new biotechnology firms, Organization Science, 3: 783–831.
McMillan, G., Narin, F., Deeds, D. (2000), An analysis of the critical role of public science in innovation: The case of biotechnology, Research Policy, 29: 1–8.
Merton, R. K. (1973), In: N. W. Storer (Ed.) The Sociology of Science: Theoretical and Empirical Investigations. University of Chicago Press, Chicago, IL.
Narin, F., Pinski, G., Gee, H. (1976), Structure of the biomedical literature, Journal of the American Society for Information Science, 27: 25–45.
Pinski, G., Narin, F. (1976), Citation influence for journal aggregates of scientific publications: Theory, with application to the literature of physics, Information Processing and Management, 12: 297–312.
Rosenberg, N. (1990), Why do firms do basic research with their own money? Research Policy, 19: 165–174.
Sorenson, O., Fleming, L. (2004), Science and the diffusion of knowledge, Research Policy, 33: 1615–1634.
Tijssen, R., Butler, R., Van Leeuwen, Th. (2000), Technological relevance of science: An assessment of citation linkages between patents and research papers, Scientometrics, 47: 389–412.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steven McMillan, G., Hamilton, R.D. The public science base of US biotechnology: A citation-weighted approach. Scientometrics 72, 3–10 (2007). https://doi.org/10.1007/s11192-007-1701-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11192-007-1701-4